SCHOENBERG MARK (Chief Medical Officer) sold 0.6% of their position (871.00 shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $16.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/9/2025ACC: 0001437749-25-028707
Officer· Chief Medical Officer
Since Jan 2019
-871.00
Net shares
Net seller
$16.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.67K acquired · 2.54K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+1.67K
Price / share
—
Trade value
—
% of position
1.1%
9/7/2025
148.23K→149.90K
Ordinary Shares
Direct
Shares
−871.00
Price / share
$19.11
Trade value
$16.64K
% of position
0.6%
9/8/2025
149.90K→149.03K
Total
Net shares
+796.00
Net value
-$16.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/7/2025 | M · Option Exercise | +1.67K | — | — | 1.1% | 148.23K | 149.90K |
| Ordinary Shares Direct | 9/8/2025 | S · Sale | −871.00 | $19.11 | $16.64K | 0.6% | 149.90K | 149.03K |
| Total | +796.00 | -$16.64K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Ordinary Shares
1.67K shares
Shares
−1.67K
Strike price
Held after
1.67K
Exercisable
—
9/7/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares1.67K shares | 9/7/2025 | M · Option Exercise | −1.67K | — | 1.67K |